Test Code NMP22 NMP22, Urine
Additional Codes
- Bladder Tumor Associated Antigen
- Nuclear Matrix Protein
Methodology
Quantitative Enzyme Immunoassay
Specimen Requirements
- Patient Preparation:
- NMP22 testing should not be performed on patients who have had a total cystectomy or within 5
- days of an invasive procedure, such as cystoscopy or catheterization of the urethra.
- Collect
- Single void of urine collected between midnight and noon. Urine Stabilization kit required.
- Specimen Preparation
- Follow instructions provided in the Urine Stabilization kit. Stabilized specimen should be blue/green in color. Urine must be added to the stabilizer immediately after collection. Send urine to Specimen Processing to do this step.
- Storage/Transport Temperature
- Frozen.
- Unacceptable Conditions:
- Urine not stabilized in NMP22 Urine Stabilizer Vial.
- Stability:
- Preserved: Ambient: 4 days; Refrigerated: 7 days; Frozen: 2 months
Performing Laboratory
ARUP Laboratories
Shipping
We send directly to ARUP.
See SPP4 600.018 for instructions.
Useful Information
Aid in diagnosis of urothelial carcinoma in conjunction with standard diagnostic procedures and monitoring for tumor recurrence.
Reference Interval : 0.0-10.0 U/mL
Interpretaive Data:
This test is intended as an aid in the management of patients with transitional cell carcinoma of the urinary tract (TCC/UT), and is used after surgical treatment to identify patients with residual or rapidly recurring TCC/UT. Values obtained with different test methods should not be used interchangeably. ARUP uses the Alere NMP22 Test Kit, an enzyme immunoassay (EIA) method.
CPT Code
86316